Journal of Medicinal Chemistry · 1988 · 61 citations · 0 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryMolecular PharmacologyStructure-activity RelationshipsConformational RestrictionMolecular SimilarityNicotine PharmacologyQuantitative Structure-activity RelationshipsStructure-activity Relationship AnalysisAgonist ActivityBiological CharacterizationChemical Structure-activity RelationshipsNicotinic Receptor Pharmacology
The recently discovered nicotinic agonist pyrido[3,4-b]norhomotropane [corrected] (PHT) as well as its N-methyl and 2'-methyl derivatives (syntheses reported herein) were compared with nicotine, nornicotine, and anatoxin a in a series of in vitro and in vivo assays. The results reveal that PHT possesses activity comparable to that of the highly potent agonist, anatoxin a. The inactivity observed relative to PHT of N-methyl- and 2'-methyl-PHT has helped to further define the structure-activity requirements of conformationally restricted nicotinoids.